ImprimisRx offers a look at three new products in the pipeline
November 14, 2021
ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.
November 14, 2021
Sunir J. Garg, MD, speaks on the influence of COVID-19 universal face masking on the risk of endophthalmitis following intravitreal anti-VEGF injections.
November 14, 2021
ImprimisRx President John Saharek shares an update on a few of the company's latest products during AAO 2021.
November 12, 2021
Bausch + Lomb's Yolande Barnard, shares an update on the FDA approval of XIPERE for the treatment of macular edema associated with uveitis.
November 04, 2021
Video
Michael Rivers, MD, director of ophthalmology, Modernizing Medicine, shares what lingers on his mind in the field of ophthalmology at the end of the day.
October 25, 2021
Article
Bausch + Lomb and Clearside Biomedical announced Monday that the U.S. Food and Drug Administration has approved XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis.
October 21, 2021
Video
JD Schaub, chief operating officer at RVL Pharmaceuticals, shares what lingers on his mind in the ophthalmic field at the end of the day.